The Re-Prosper HF Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jack Rubinstein, MD
Cincinnati VA Medical Center, Cincinnati, OH
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Va Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, Ma
Boston, Massachusetts, United States
- Cincinnati Va Medical Center, Cincinnati, Oh
Cincinnati, Ohio, United States
- Louis Stokes Va Medical Center, Cleveland, Oh
Cleveland, Ohio, United States
- Providence Va Medical Center, Providence, Ri
Providence, Rhode Island, United States
- Hunter Holmes Mcguire Va Medical Center, Richmond, Va
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Jun 2021
- Primary completion
- 31 Dec 2025
- Completion
- 31 Dec 2025
- Last update posted
- 7 Jan 2026
- Registered enrollment
- 99
- Registry id
- NCT04551222
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.